Noncardiac Comorbidities in Heart failure with Reduced Versus Preserved ejection Fraction

Overview

Journal J Am Coll Cardiol

Specialty Cardiology & Vascular Diseases

Date 2014 Dec 3

PMID 25456761

Citations 212

Authors

Robert J Mentz

Jacob P Kelly

Thomas G von Lueder

Adriaan A Voors

Carolyn S P Lam

Martin R Cowie

Keld Kjeldsen

Ewa A Jankowska

Dan Atar

Javed Butler

Mona Fiuzat

Faiez Zannad

Bertram Pitt

Christopher M OConnor

Affiliations

Soon will be listed here.

Abstract

Heart failure patients are classified by ejection fraction (EF) into distinct groups: heart failure with preserved ejection fraction (HFpEF) or heart failure with reduced ejection fraction (HFrEF). Although patients with heart failure commonly have multiple comorbidities that complicate management and may adversely affect outcomes, their role in the HFpEF and HFrEF groups is not well-characterized. This review summarizes the role of noncardiac comorbidities in patients with HFpEF versus HFrEF, emphasizing prevalence, underlying pathophysiologic mechanisms, and outcomes. Pulmonary disease, diabetes mellitus, anemia, and obesity tend to be more prevalent in HFpEF patients, but renal disease and sleep-disordered breathing burdens are similar. These comorbidities similarly increase morbidity and mortality risk in HFpEF and HFrEF patients. Common pathophysiologic mechanisms include systemic and endomyocardial inflammation with fibrosis. We also discuss implications for clinical care and future HF clinical trial design. The basis for this review was discussions between scientists, clinical trialists, and regulatory representatives at the 10th Global CardioVascular Clinical Trialists Forum.

Citing Articles

Prior hospitalizations as a predictor of prognosis in heart failure with mildly reduced ejection fraction.

Steffen H, Behnes M, Schmitt A, Abel N, Lau F, Reinhardt M Clin Res Cardiol. 2025; .

PMID: 39964615 DOI: 10.1007/s00392-025-02612-9.

Increasing Readmissions of HFpEF and the Burden They Cause.

Kim M, Lee C Int J Heart Fail. 2025; 7(1):30-31.

PMID: 39911572 PMC: 11791177. DOI: 10.36628/ijhf.2025.0001.

Timing of acute decompensated heart failure in patients with heart failure and mildly reduced ejection fraction.

Steffen H, Abel N, Lau F, Schmitt A, Reinhardt M, Akin M Heart Vessels. 2025; .

PMID: 39841200 DOI: 10.1007/s00380-024-02505-3.

Time course of hospitalizations in patients with heart failure and chronic obstructive pulmonary disease around sleep-disordered-breathing diagnosis.

Tafelmeier M, Malfertheiner M, Zeman F, Penzel T, Schoebel C, Randerath W Sleep Breath. 2025; 29(1):79.

PMID: 39812882 PMC: 11735569. DOI: 10.1007/s11325-024-03242-7.

Medical Costs and Economic Impact of Hyperkalemia in a Cohort of Heart Failure Patients with Reduced Ejection Fraction.

Lopez-Lopez A, Regueiro-Abel M, Paredes-Galan E, Johk-Casas C, Vieitez-Florez J, Elices-Teja J J Clin Med. 2025; 14(1.

PMID: 39797142 PMC: 11720833. DOI: 10.3390/jcm14010058.

References

Nieminen M, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola V . EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J. 2006; 27(22):2725-36. DOI: 10.1093/eurheartj/ehl193. View

Boudina S, Abel E . Diabetic cardiomyopathy revisited. Circulation. 2007; 115(25):3213-23. DOI: 10.1161/CIRCULATIONAHA.106.679597. View

Scirica B, Bhatt D, Braunwald E, Steg P, Davidson J, Hirshberg B . Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. N Engl J Med. 2013; 369(14):1317-26. DOI: 10.1056/NEJMoa1307684. View

Hillege H, Nitsch D, Pfeffer M, Swedberg K, McMurray J, Yusuf S . Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation. 2006; 113(5):671-8. DOI: 10.1161/CIRCULATIONAHA.105.580506. View

Young J, Abraham W, Albert N, Stough W, Gheorghiade M, Greenberg B . Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry). Am J Cardiol. 2008; 101(2):223-30. DOI: 10.1016/j.amjcard.2007.07.067. View

Dhingra R, Vasan R . Diabetes and the risk of heart failure. Heart Fail Clin. 2011; 8(1):125-33. PMC: 3223386. DOI: 10.1016/j.hfc.2011.08.008. View

. Standards of medical care in diabetes--2013. Diabetes Care. 2012; 36 Suppl 1:S11-66. PMC: 3537269. DOI: 10.2337/dc13-S011. View

Cleland J, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar J . The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J. 2003; 24(5):442-63. DOI: 10.1016/s0195-668x(02)00823-0. View

Barr R, Bluemke D, Ahmed F, Carr J, Enright P, Hoffman E . Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med. 2010; 362(3):217-27. PMC: 2887729. DOI: 10.1056/NEJMoa0808836. View

10.

Komajda M, McMurray J, Beck-Nielsen H, Gomis R, Hanefeld M, Pocock S . Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial. Eur Heart J. 2010; 31(7):824-31. PMC: 2848325. DOI: 10.1093/eurheartj/ehp604. View

11.

Herrscher T, Akre H, Overland B, Sandvik L, Westheim A . High prevalence of sleep apnea in heart failure outpatients: even in patients with preserved systolic function. J Card Fail. 2011; 17(5):420-5. DOI: 10.1016/j.cardfail.2011.01.013. View

12.

Blair J, Pang P, Schrier R, Metra M, Traver B, Cook T . Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial. Eur Heart J. 2011; 32(20):2563-72. DOI: 10.1093/eurheartj/ehr238. View

13.

Wang H, Parker J, Newton G, Floras J, Mak S, Chiu K . Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol. 2007; 49(15):1625-1631. DOI: 10.1016/j.jacc.2006.12.046. View

14.

Waldum B, Os I . The cardiorenal syndrome: what the cardiologist needs to know. Cardiology. 2013; 126(3):175-86. DOI: 10.1159/000353261. View

15.

Swedberg K, Young J, Anand I, Cheng S, Desai A, Diaz R . Treatment of anemia with darbepoetin alfa in systolic heart failure. N Engl J Med. 2013; 368(13):1210-9. DOI: 10.1056/NEJMoa1214865. View

16.

Lau Y, Lane D, Lip G . Atrial fibrillation and heart failure: a bad combination. Am J Cardiol. 2014; 113(7):1196-7. DOI: 10.1016/j.amjcard.2014.01.002. View

17.

Mentz R, Schulte P, Fleg J, Fiuzat M, Kraus W, Pina I . Clinical characteristics, response to exercise training, and outcomes in patients with heart failure and chronic obstructive pulmonary disease: findings from Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION). Am Heart J. 2013; 165(2):193-9. PMC: 3762597. DOI: 10.1016/j.ahj.2012.10.029. View

18.

Bradley T, Logan A, Kimoff R, Series F, Morrison D, Ferguson K . Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med. 2005; 353(19):2025-33. DOI: 10.1056/NEJMoa051001. View

19.

Schannwell C, Schneppenheim M, Perings S, Plehn G, Strauer B . Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy. Cardiology. 2002; 98(1-2):33-9. DOI: 10.1159/000064682. View

20.

Ferrier K, Campbell A, Yee B, Richards M, OMeeghan T, Weatherall M . Sleep-disordered breathing occurs frequently in stable outpatients with congestive heart failure. Chest. 2005; 128(4):2116-22. DOI: 10.1378/chest.128.4.2116. View